# Comparative Study of High-Efficacy Disease Modifying Treatment of Relapsing Multiple Sclerosis

> **NCT06159712** · NA · UNKNOWN · sponsor: **University of Aarhus** · enrollment: 200 (estimated)

## Conditions studied

- Relapsing Remitting Multiple Sclerosis

## Interventions

- **OTHER:** Blood samples

## Key facts

- **NCT ID:** NCT06159712
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-27
- **Primary completion:** 2024-11
- **Final completion:** 2025-11
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-12-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06159712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06159712, "Comparative Study of High-Efficacy Disease Modifying Treatment of Relapsing Multiple Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06159712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
